Insulet (PODD) Revenue — Quarter Ended Sep 30, 2023
Revenue increased compared to both the immediately preceding quarter and the same quarter one year earlier. The year-over-year growth was more pronounced than the sequential increase.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue increased compared to both the immediately preceding quarter and the same quarter one year earlier. The year-over-year growth was more pronounced than the sequential increase.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$432.7M
Revenue reported for this quarter.
Quarter-over-quarter
+9.1%
Change from the immediately preceding quarter.
Year-over-year
+27.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $369.7M | +13.1% |
| Mar 31, 2023 | $358.1M | +45.0% |
| Jun 30, 2023 | $396.5M | +32.4% |
| Sep 30, 2023 | $432.7M | +27.0% |
Revenue performance
Revenue rose, and the company maintained a solid liquidity position with ample cash and a manageable debt structure.
Quarterly comparison
Sequentially, revenue improved from the prior three-month period. On a year-over-year basis, revenue also posted a healthy gain.
What to watch
The debt-to-total capital ratio declined, signaling a more conservative financial structure.